A global distributor of numerous radiopharmaceuticals, including theranostics drugs, Cardinal Health  was seeking to increase awareness and improve understanding of gallium-68, an isotope that offered many benefits but suffered from some industry misconceptions that negatively impacted preference. The company came to Lunne for strategy and a brand-agnostic campaign to dispel myths, highlight advantages, and encourage use of gallium-based products.

We partnered with the Nuclear & Precision Health team to understand the nuances of PET isotopes and the key areas in which gallium offered benefits over others: accuracy, scalability, and access. We then developed compelling marketing messages and bold campaign creative that spotlighted the possibilities only gallium-based products can unlock. The campaign was later executed across multiple digital platforms.